A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. (Q50561584)
scientific article published in February 1998
Language:
(P31) (Q13442814)
(P50) (Q43979926)
(Q56849196)
(P304) 135-146
(P433) 2
(P478) 46
(P577) Sunday, February 1, 1998
(P921) (Q180507)
(Q9637)
(Q105688)
(Q1783924)
(Q18966654)
(Q18554836)
(P1433) (Q14251029)
(P1476) "A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85" (language: en)
(P2093) J Overgaard
H S Hansen
M Overgaard
A Berthelsen
B Lindeløv
K Jørgensen
(P2860) (Q73677928)
(Q41715164)
(Q40895017)
(Q33862670)
(Q41757804)
(Q41591209)
(Q39613843)
(Q73677937)
(Q68872807)
(Q73728101)
(Q68172087)
(Q42196678)
(Q34437356)
(Q72097937)
(Q73370364)
(Q39442588)
(Q39442595)
(Q73677933)
(Q40405347)
(Q68927383)
(Q73370377)
(Q72333641)
(Q41244434)
(Q70217423)
(Q71877350)
(Q38367398)
(Q42100818)
(Q50545311)
(Q39237055)
(Q36047240)
(Q36047884)
(Q69491043)
(Q74019855)
(Q46941838)
(Q68417268)
(Q44868710)
(Q70620541)
other details
description scientific article published in February 1998

External Links